Detailed information for compound 2124591

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 449.114 | Formula: C24H20ClN3O4
  • H donors: 1 H acceptors: 4 LogP: 5.07 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(c1ccc2c(c1)c(Oc1c(C)cccc1Cl)nn2c1ccc(cc1)C(=O)O)N(C)C
  • InChi: InChI=1S/C24H20ClN3O4/c1-14-5-4-6-19(25)21(14)32-22-18-13-16(23(29)27(2)3)9-12-20(18)28(26-22)17-10-7-15(8-11-17)24(30)31/h4-13H,1-3H3,(H,30,31)
  • InChiKey: SLLXKTYZEFJLBH-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens RAR-related orphan receptor C References
Homo sapiens retinoic acid receptor, gamma References
Homo sapiens RAR-related orphan receptor A References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_131607 All targets in OG5_131607
Brugia malayi nuclear hormone receptor Get druggable targets OG5_131607 All targets in OG5_131607
Onchocerca volvulus Steroid hormone receptor family member cnr14 homolog Get druggable targets OG5_131607 All targets in OG5_131607
Loa Loa (eye worm) nuclear receptor nhr-7B Get druggable targets OG5_131607 All targets in OG5_131607

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni thyroid hormone receptor 0.0037 0 0.5
Schistosoma mansoni coup transcription factor 0.0037 0 0.5
Echinococcus granulosus nuclear receptor 2DBD gamma 0.0037 0 0.5
Echinococcus granulosus ecdysone induced protein 78C 0.0037 0 0.5
Echinococcus granulosus hepatocyte nuclear factor 4 alpha 0.0037 0 0.5
Echinococcus multilocularis FTZ F1 nuclear receptor protein 0.0037 0 0.5
Schistosoma mansoni nuclear hormone receptor nor-1/nor-2 0.0037 0 0.5
Schistosoma mansoni steroid hormone receptor ad4bp 0.0037 0 0.5
Schistosoma mansoni Tr4/Tr2 (homologue) 0.0037 0 0.5
Brugia malayi nuclear hormone receptor 0.0274 0.9246 1
Loa Loa (eye worm) hypothetical protein 0.0256 0.8572 0.9271
Echinococcus multilocularis hepatocyte nuclear factor 4 alpha 0.0037 0 0.5
Schistosoma mansoni nuclear hormone receptor 0.0037 0 0.5
Schistosoma mansoni FTZ-F1 nuclear receptor-like protein 0.0037 0 0.5
Echinococcus multilocularis FTZ F1 alpha 0.0037 0 0.5
Echinococcus multilocularis nuclear receptor 2DBD gamma 0.0037 0 0.5
Echinococcus multilocularis thyroid hormone receptor alpha 0.0037 0 0.5
Loa Loa (eye worm) nuclear receptor nhr-7B 0.0274 0.9246 1
Echinococcus multilocularis Nuclear hormone receptor family member nhr 41 0.0037 0 0.5
Echinococcus multilocularis ecdysone induced protein 78C 0.0037 0 0.5
Echinococcus granulosus Nuclear hormone receptor family member nhr 41 0.0037 0 0.5
Echinococcus granulosus FTZ F1 nuclear receptor protein 0.0037 0 0.5
Schistosoma mansoni thyroid hormone receptor 0.0037 0 0.5
Schistosoma mansoni RAR-like nuclear receptor 0.0037 0 0.5
Schistosoma mansoni nuclear receptor 2DBD-gamma 0.0037 0 0.5
Echinococcus multilocularis nuclear receptor 2DBD gamma 0.0037 0 0.5
Schistosoma mansoni retinoic acid receptor RXR 0.0037 0 0.5
Schistosoma mansoni retinoid-x-receptor (RXR) 0.0037 0 0.5
Echinococcus granulosus retinoic acid receptor rxr beta a 0.0037 0 0.5
Echinococcus granulosus FTZ F1 alpha 0.0037 0 0.5
Echinococcus granulosus COUP TF:Svp nuclear hormone receptor 0.0037 0 0.5
Schistosoma mansoni photoreceptor-specific nuclear receptor related 0.0037 0 0.5
Echinococcus granulosus nuclear receptor 2DBD gamma 0.0037 0 0.5
Echinococcus multilocularis COUP TF:Svp nuclear hormone receptor 0.0037 0 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 120 nM Inverse agonist activity at GAL4 DBD-fused RORgammat LBD (unknown origin) expressed in HG5LN cells after 18 hrs by luciferase reporter gene assay LITERATURE. 27815118
IC50 (binding) = 150 nM Inverse agonist activity at RORgamma in human CD4+ T cells assessed as inhibition of IL-17A release after 4 days by HTRF assay LITERATURE. 27815118
IC50 (binding) > 10000 nM Inverse agonist activity at GAL4 DBD-fused RORalpha LBD (unknown origin) expressed in HG5LN cells after 18 hrs by luciferase reporter gene assay LITERATURE. 27815118
IC50 (binding) > 10000 nM Inverse agonist activity at GAL4 DBD-fused RARgamma LBD (unknown origin) expressed in human HG5LN cells after 18 hrs by luciferase reporter gene assay LITERATURE. 27815118
Kd(app) (binding) Activity at 24 hydroxylase-fused VDR in human HG5LN cells after 18 hrs by luciferase reporter gene assay LITERATURE. 27815118
Kd(app) (binding) Activity at GAL4 DBD-fused PPARgamma LBD (unknown origin) expressed in HG5LN cells after 18 hrs by luciferase reporter gene assay LITERATURE. 27815118
Kd(app) (binding) Activity at GAL4 DBD-fused LXRbeta LBD (unknown origin) expressed in human HG5LN cells after 18 hrs by luciferase reporter gene assay LITERATURE. 27815118

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.